154
Participants
Start Date
May 31, 2014
Primary Completion Date
July 31, 2016
Study Completion Date
September 5, 2017
Filanesib, KSP (Eg5) inhibitor; intravenous
multiple dose, single schedule
Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
standard of care
Mount Sinai Medical Center, New York
NY Presbyterian - Weill Cornell Medical Center, New York
Center for Cancer and Blood Disorders, Bethesda
Duke Cancer Center, Durham
Levine Cancer Institute, Charlotte
Medical University of South Carolina, Charleston
Emory University, Winship Cancer Institute, Atlanta
UAB Comprehensive Cancer Center, Birmingham
Norton Cancer Institute, Louisville
University of Kentucky, Lexington
Cleveland Clinic, Cleveland
Karmanos Cancer Institute, Detroit
Northwestern University, Chicago
Rush University Medical Center, Chicago
Decatur Memorial Hospital, Decatur
Washington University in St. Louis, St Louis
University of Kansas Cancer Center and Medical Pavilion, Westwood
Nebraska Hematology Oncology, P.C., Lincoln
UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
University of Colorado, Aurora
Colorado Blood Cancer Institute, Denver
Huntsman Cancer Institute, Salt Lake City
Comprehensive Cancer Centers of Nevada, Las Vegas
City of Hope, Duarte
University of California, San Francisco Medical Center, San Francisco
Cancer Care Northwest, Spokane Valley
Yale Comprehensive Cancer Center, New Haven
Tufts Medical Center, Boston
Institut Jules Bordet, Brussels
Universitaire Ziekenhuizen Leuven, Leuven
Tom Baker Cancer Centre, Calgary
QEII Health Sciences Center, Halifax
Jewish General Hospital, Montreal
Centre Hospitalier Lyon-Sud, Bierre-Benite Cedex
Hopital Claude Huriez, Lille
Institut Paoli Calmettes, Marseille
CHU Hotel Dieu, Nantes
G.H.U Caremeau, Nîmes
Institut Universitaire de Cancer, Toulouse
CHU tours-Hopital Bretonneau, Tours
CHU de Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy
TU Dresden Medizinische Fakultat, Medizinische Klinik und Poliklinik I, Dresden
Asklepios Kliniken Hamburg GmbH, Hamburg
University Hospital Heidelberg, Heidelberg
University Hospital Leipzig, Leipzig
University of Tubingen, Tübingen
Julius Maximilians Universitat Wurzburg, Würzburg
"General Hospital of Athens Evangelismos", Athens
University of Athens School of Medicine, Athens
Hospital Germans Trias i Pujol, Badalona
Hospital Clinic de Barcelona, Barcelona
Hospital Clinico Universitario de Valencia, Valencia
Hospital Universitario La Fe, Valencia
Hospital Quiron de Zaragoza, Zaragoza
Barts Health NHS Trust, London
Kings College Hospital NHS Foundation Trust, London
Southhampton General Hospital, Southhampton
The Royal Marsden NHS Foundation Trust, Surrey
New Cross Hospital, Wolverhampton
Lead Sponsor
Pfizer
INDUSTRY